Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab Meeting Abstract

   

Authors:	Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; Busam, K. J.; Feely, W.; Jure-Kunkel, M.; Grosso, J.; Simon, J. S.; Korman, A. J.; Wigginton, J. M.; Gupta, A. K.; Zhang, X.; Phillips, T.; Simmons, P.; Sznol, M.; Wolchok, J. D.
Abstract Title:	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
Meeting Title:	28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Journal Title:	Journal for ImmunoTherapy of Cancer
Volume:	1
Issue:	Suppl. 1
Meeting Dates:	2013 Nov 8-10
Meeting Location:	National Harbor, MD
ISSN:	2051-1426
Publisher:	Biomed Central Ltd
Date Published:	2013-11-07
Language:	English
DOI:	10.1186/2051-1426-1-S1-O6
PROVIDER:	manual
PMCID:	PMC3991225
Notes:	Meeting Abstract: O6